As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy